About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 2/3NCT00305630

Neovascular Age Related Macular Degeneration (AMD), Periocular Corticosteroids, and Photodynamic Therapy (PDT)

Randomized controlled clinical trial of periocular corticosteroids as adjunctive therapy to photodynamic therapy (PDT) for patients with neovascular age-related macular degeneration (AMD). Patients un...

Lead sponsor: Johns Hopkins University•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Johns Hopkins University

Collaborators

Oregon Health and Science University

Age

50 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Active choroidal neovascularization
•Age related macular degeneration
•Visual acuity 20/20 to 20/400

Exclusion Criteria

•Neovascular lesion \>6500 microns is greatest linear diameter
•More than one prior photodynamic therapy treatment
•Receiving systemic corticosteroids
•Intraocular pressure \> 21 mm Hg or glaucoma medication use
•History of glaucoma or history of ocular hypertension

Related studies

National Eye Institute Biorepository for Retinal Diseases

NCT01496625 · Age-Related Macular Degeneration, Diabetic Retinopathy, and more

RECRUITINGPhase 2

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

NCT06990269 · Geographic Atrophy Secondary to Age-related Macular Degeneration

RECRUITINGPhase 1/2

Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration

NCT07587515 · Neovascular (Wet) Age-Related Macular Degeneration

RECRUITINGPhase 1

Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)

NCT05803785 · Age-Related Macular Degeneration

RECRUITINGEARLY Phase 1

The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma

NCT06593405 · Age-Related Macular Degeneration

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 22, 2006Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2/PHASE3

Enrollment100

Start dateJul 2002

Last updatedMar 22, 2006

Condition

Choroidal Neovascularization Age-Related Macular Degeneration

Locations shown

Johns Hopkins Univeristy School of Medicine

Baltimore, Maryland

Oregon Health Science Univeristy

Portland, Oregon

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 22, 2006Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions